Solid Lipid Nanospheres (SLN) are colloidal therapeutic systems proposed for several
administration routes and obtained by dispersing warm microemulsions in cold water. SLN …

The pharmacokinetics of doxorubicin incorporated as ion-pair into solid lipid nanospheres
(SLN) was compared with that of the commercial solution of the drug. Male albino rats …

Solid lipid nanoparticles (SLN) loaded with doxorubicin were prepared by solvent
emulsification-diffusion method. Glyceryl caprate (Capmul® MCM C10) was used as lipid …

Solid lipid nanoparticles (SLN) carrying cholesteryl butyrate (chol-but), doxorubicin and
paclitaxel had previously been developed, and the antiproliferative effect of SLN …

Solid lipid nanoparticles (SLNs) comprise a versatile drug delivery system that has been
developed for the treatment of a variety of diseases. The present study will investigate the …

Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin were prepared
as drug delivery systems. The pharmacokinetics and tissue distribution of doxorubicin in …

Solid lipid nanoparticles (SLN) are considered at the forefront of nanotechnology's rapidly
developing field, with several potential applications in drug delivery and research. SLN …

The prospect of improved cancer chemotherapy using solid lipid nanoparticles (SLN) as a
drug delivery system is promising. Several obstacles frequently encountered with anticancer …

Lipid microspheres can act as a carrier for antitumor agents. We incorporated a lipophilic
antitumor agent, l, 3-bis (2-chloroethyl)-1-nitrosourea (BCNU) into microspheres by …

Purpose. Assessment of the in vitro cytotoxicity of solid lipid nanoparticles (SLNs) as a
function of lipid matrix (Dynasan 114, Compritol ATO 888), and stabilizing surfactant …